FR2296415A1 - PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CIRCULATION DISORDERS - Google Patents

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CIRCULATION DISORDERS

Info

Publication number
FR2296415A1
FR2296415A1 FR7600014A FR7600014A FR2296415A1 FR 2296415 A1 FR2296415 A1 FR 2296415A1 FR 7600014 A FR7600014 A FR 7600014A FR 7600014 A FR7600014 A FR 7600014A FR 2296415 A1 FR2296415 A1 FR 2296415A1
Authority
FR
France
Prior art keywords
treatment
pharmaceutical preparations
circulation disorders
disorders
circulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7600014A
Other languages
French (fr)
Other versions
FR2296415B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of FR2296415A1 publication Critical patent/FR2296415A1/en
Application granted granted Critical
Publication of FR2296415B1 publication Critical patent/FR2296415B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/625—Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicycloylmorpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7600014A 1975-01-06 1976-01-02 PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CIRCULATION DISORDERS Granted FR2296415A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH7175 1975-01-06
CH1474775 1975-11-13

Publications (2)

Publication Number Publication Date
FR2296415A1 true FR2296415A1 (en) 1976-07-30
FR2296415B1 FR2296415B1 (en) 1978-08-18

Family

ID=25683420

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7600014A Granted FR2296415A1 (en) 1975-01-06 1976-01-02 PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CIRCULATION DISORDERS

Country Status (10)

Country Link
JP (1) JPS5191314A (en)
AU (1) AU499139B2 (en)
BE (1) BE837294A (en)
CA (1) CA1059914A (en)
DE (1) DE2600021A1 (en)
FR (1) FR2296415A1 (en)
GB (1) GB1500300A (en)
IE (1) IE42765B1 (en)
IL (1) IL48787A (en)
NL (1) NL7600047A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014514A2 (en) * 1979-02-02 1980-08-20 Orion-Yhtymä Oy Process for the preparation of tablets

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN151913B (en) * 1980-01-11 1983-09-03 Boots Co Ltd
US5731339A (en) * 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response
FI20060501L (en) * 2006-05-22 2007-11-23 Biohit Oyj Composition and method for binding acetaldehyde in the stomach
WO2008013084A1 (en) * 2006-07-25 2008-01-31 Kowa Company, Ltd. Sugar-coated preparation and process for producing the same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL51480C (en) *
FR1013681A (en) * 1947-01-31 1952-08-01 Ciba Geigy New imidazolines and process for their manufacture

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL51480C (en) *
FR1013681A (en) * 1947-01-31 1952-08-01 Ciba Geigy New imidazolines and process for their manufacture

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014514A2 (en) * 1979-02-02 1980-08-20 Orion-Yhtymä Oy Process for the preparation of tablets
EP0014514A3 (en) * 1979-02-02 1981-06-10 Orion-Yhtyma Oy Process for the preparation of tablets

Also Published As

Publication number Publication date
IE42765L (en) 1976-07-06
BE837294A (en) 1976-07-05
AU1000176A (en) 1977-07-14
FR2296415B1 (en) 1978-08-18
JPS5191314A (en) 1976-08-10
DE2600021A1 (en) 1976-07-15
IL48787A (en) 1978-09-29
CA1059914A (en) 1979-08-07
IE42765B1 (en) 1980-10-08
IL48787A0 (en) 1976-03-31
GB1500300A (en) 1978-02-08
NL7600047A (en) 1976-07-08
AU499139B2 (en) 1979-04-05

Similar Documents

Publication Publication Date Title
FR2348201A1 (en) NEW DRUGS FOR THE TREATMENT OF ISCHEMIC VASCULAR DISORDERS
FR2316954A1 (en) DENTAL PREPARATION FOR THE TREATMENT OF PERIODONTOSIS
FR2333515A1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CALCIUM METABOLISM DISORDERS
BE854416A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF MENOPAUSE AND THEIR METHOD OF USE
BE865156A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DEPRESSIONS
FR2341315A1 (en) MEDICINES FOR THE TREATMENT OF NEUROPATHIES
BE885291A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CARDIAC DYSFUNCTION
BE829859A (en) PHARMACEUTICAL METHODS AND COMPOSITIONS FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA
FR2310769A1 (en) MEDICINAL PRODUCT FOR THE TREATMENT OF ALOPECIA SEBORRHOEICA
BE773121A (en) PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF HYPERLIPIDEMIA AND THEIR PROCESS FOR OBTAINING THEIR
BE837294A (en) PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CIRCULATION DISORDERS
FR2311553A1 (en) MEDICINE FOR THE TREATMENT OF SCHIZOPHRENIA
BE814735A (en) NEW PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HEART DISEASE
BE809832A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES
FR2310770A1 (en) MEDICINAL PRODUCT FOR THE TREATMENT OF ALOPECIA AREATA
BE842389A (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HYPERURICEMIA
FR2310768A1 (en) MEDICINE FOR THE TREATMENT OF ALOPECIA SENILIS
FR2310767A1 (en) MEDICINE FOR THE TREATMENT OF ALOPECIA CHRONICA DIFFUSA
BE860239A (en) MEDICINAL PREPARATION FOR THE TREATMENT OF MALIGNANT NEOFORMATIONS
ZA7628B (en) Pharmaceutical preparation for the treatment of circulatory disorders
BE791253A (en) NEW PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF HYPERTONIA
BE812974A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ULCERS
BE829024A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HYDROPISIS
BE809833A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PROLIFERANT SKIN DISEASES
BE786326A (en) NEW PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISORDERS OF INTESTINAL SECRETION

Legal Events

Date Code Title Description
ST Notification of lapse